JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.

Jiangsu Jibeier Pharmaceutical Co., Ltd.

688566

CNE100004041

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 16/07/2024 am IST			5-day change	1st Jan Change
21.35 ^CNY	-0.23%		-0.84%	-31.98%

05/06	Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it has received CNY 198.161716 million in funding from a group of investors	CI
21/05	Jibeier Pharmaceutical Gets Patents for Two Products	MT

Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it has received CNY 198.161716 million in funding from a group of investors

June 05, 2024

On June 5, 2024, Jiangsu Jibeier Pharmaceutical Co., Ltd. closed the transaction. The company has issued 7,446,889 shares in the transaction. The transaction includes participation of individual investor and group of other investors.

On June 6, 2024, the transaction has been approved by the China Securities Regulatory Commission.

Latest news about Jiangsu Jibeier Pharmaceutical Co., Ltd.

Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it has received CNY 198.161716 million in funding from a group of investors	05/06	CI
Jibeier Pharmaceutical Gets Patents for Two Products	21/05	MT
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Jibeier Pharmaceutical's Taxane Compound Method Gets Patent; Shares Down 3%	08/04	MT
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/02	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd.(XSSC:688566) added to S&P Global BMI Index	18/23/18	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it expects to receive CNY 298.1619 million in funding	02/23/02	CI
Certain A Shares of Jiangsu Jibeier Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2023.	18/23/18	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	17/22/17	CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/22/29	CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	19/21/19	CI
Yee Hop : Sells 30% Stake in Research Arm to Jiangsu Jibeier	13/21/13	MT
Shenzhen Huahong Marine Biological Medicine Co., Ltd announced that it expects to receive CNY 90 million in funding from Shenzhen BGI Marine Sci & Tech Co.Ltd, JiangsuJibeier Pharmaceutical Co., Ltd.	02/21/02	CI
Jiangsujibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	26/21/26	CI
JiangsuJibeier Pharmaceutical Co., Ltd.(SHSE:688566) added to Shanghai Stock Exchange Composite Index	21/21/21	CI
JiangsuJibeier Pharmaceutical Co., Ltd.(SHSE:688566) added to Shanghai Stock Exchange A Share Index	21/21/21	CI
Certain A Shares of JiangsuJibeier Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2021.	18/21/18	CI
JiangsuJibeier Pharmaceutical Co., Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	28/21/28	CI
Jiangsujibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	28/21/28	CI

Chart Jiangsu Jibeier Pharmaceutical Co., Ltd.

Duration

Period

Chart Jiangsu Jibeier Pharmaceutical Co., Ltd.

More charts

Company Profile

Jiangsu Jibeier Pharmaceutical Co Ltd is a company engaged in the research, development, production and sales of drugs. The Company's products are comprised of tablets, capsules and eye drops. The tablet products include Leucogen tablets, Nitrendipine and Atenolol tablets, Aceclofenac Enteric-coated tablets and Asarone tablets. The Company's products are used to improve white blood cells, treat high blood pressure, eye infections and other diseases.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Jiangsu Jibeier Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

21.4

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.	-31.98%	558M
MERCK KGAA	+6.73%	72.01B
KYOWA KIRIN CO. LTD.	+30.80%	10.39B
YUHAN CORPORATION	+41.28%	5.26B
SK BIOPHARMACEUTICALS CO., LTD.	-18.53%	4.64B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+18.24%	3.7B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+27.58%	2.3B
BETTA PHARMACEUTICALS CO., LTD.	-39.52%	1.8B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-45.87%	1.7B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals